Search
Carlsmed Ord Shs
CARLAdd to Watchlist
10.690USD
+0.850+8.64%
Close 06/23, 16:00（ET）Quotes delayed by 15 min
284.18MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
5
analysts
Buy
Current Rating
18.400
Target Price
+86.99%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Carlsmed Ord Shs
CARL
5
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
31
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Carlsmed Ord Shs's expected revenue for the next quarter?
Carlsmed Ord Shs's expected revenue is 18.00M.
What is Carlsmed Ord Shs's price target?
Analysts forecast that Carlsmed Ord Shs's price target is USD 19.00, with the highest forecast at USD 24.00 and the lowest forecast at USD 17.00.
How have Carlsmed Ord ShsCARL's recent earnings per share performed?
The market expectation was USD -0.32, while Carlsmed Ord ShsCARL's earnings per share (EPS) for the previous quarter was USD -0.32. EPS for the next quarter is expected at USD -0.40.
What is the analyst rating for Carlsmed Ord Shs?
Based on the ratings of Carlsmed Ord Shs's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
